openPR Logo
Press release

Alopecia Treatment Market Analysis of Valuable Foresights on How Alopecia Treatment will Grow by 2026 Evaluated By Global Players Cipla Limited, GlaxoSmithKline Plc., Histogen, Inc., Aclaris Therapeutics, Inc., Concert Pharmaceuticals, Inc., Daiichi Sanky

01-28-2019 08:41 AM CET | Health & Medicine

Press release from: Coherent Market Insights

Global Alopecia Treatment Market

Global Alopecia Treatment Market

Alopecia also called as hair loss or baldness is very common condition affecting people across the globe. Alopecia can affect people of all gender and at any stage of life, it generally it affects mid-aged generation. For instance, according the data published by Arch Argent Pediatr in 2017, the prevalence of Alopecia areata is high in the age group of 10 and 25 years and around 60% of people under these age group suffer from Alopecia areata.

Market Dynamics

Product launches, approvals, and robust pipeline of novel products is expected to be the major driver of growth of the global alopecia treatment market. For instance, in 2016, Cellmid Limited, a wholly owned subsidiary, Advangen Limited launched new hair loss product évolis in U.S. market. In May 2018, Histogen, Inc., received approval of its Investigational New Drug (IND) application from the U.S. Food and Drug Administration (FDA) to study its lead product Hair Stimulating Complex (HSC660) in female diffuse hair loss. HSC660 is an investigational injectable treatment for alopecia and is expected to get FDA approval in near future. Key players in the market are engaged in strategic collaborations for increasing geographic presence in market. For instance, in May 2018, Cellmid Limited signed a collaborative agreement with Beijing Fukangren Bio-pharm Tech Co Ltd. for distribution of its product in Peoples Republic of China. Furthermore, the increasing prevalence of alopecia worldwide is expected to drive the growth of market. For instance, according to the data published by National Center for Biotechnology Information (NCBI), in 2015, androgenetic alopecia is most prevalent autoimmune disorder and the second most prevalent hair loss disorder and around 2% population worldwide is suffering from androgenetic alopecia.

For More Information, Browse Here: https://www.coherentmarketinsights.com/market-insight/alopecia-treatment-market-1847

Frequent launch, approvals, and robust pipeline of alopecia treatment products is expected to drive the growth of market

In recent past, regulatory bodies have approved novel drugs for treatment of alopecia and many drugs are in pipeline, which are expected to receive approval in near future. Approval of novel drugs and presence of robust drug pipeline is expected to drive global alopecia treatment market growth in near future. For instance, in January 2018, Concert Pharmaceuticals, Inc., a U.S.-based company received Fast Track designation from U.S. Food and Drug Administration (FDA) for its novel product CTP-543. CTP-543 is a novel, oral Janus kinase (JAK) inhibitor for the treatment of moderate-to-severe alopecia areata. In April 2018, Concert Pharmaceuticals, Inc., finished patient recruitment for Phase 2a trial evaluating CTP-543 for the treatment of moderate-to-severe alopecia areata. In January 2018, HCell Inc., a Texas-based biotechnology company received Orphan Drug Designation (ODD) for HC017AA drug from U.S. Food and Drug Administration (FDA). HC017AA is an underdevelopment drug indicated for non- surgical treatment for Alopecia Areata in Pediatric Patients. In 2016, Galderma Laboratories, L.P., a company focused on development of dermatology and skin health launched its new qilib Hair Regrowth + Revitalization System and qilib Hair Health Reinforcement Biotin + Multivitamin Supplement. The qilib system is indicated for hair regrowth and contains clinically proven, prescription-strength minoxidil specifically formulated for men (5% minoxidil) or women (2% minoxidil). In 2017, Perrigo Company Plc. Launched over-the-counter (OTC) Women's Rogaine 5% minoxidil foam (minoxidil topical aerosol, 5% foam). Women's Rogaine 5% minoxidil foam (minoxidil topical aerosol, 5% foam) is indicated to regrow hair on top of the scalp. The launches of such novel products in market is expected to drive the global alopecia market growth in near future.

The global alopecia treatment market size was valued at US$ 7.4 Bn in 2017, and is expected to witness a CAGR of 5.6% over the forecast period (2018 – 2026).

Increasing prevalence of alopecia is expected to propel demand for its treatment drugs

According to the data published by National Center for Biotechnology Information (NCBI), in 2015, androgenetic alopecia is most prevalent autoimmune disorder and the second most prevalent hair loss disorder with around 2% population worldwide suffering from androgenetic alopecia. According the data published by Arch Argent Pediatr, in 2017, the prevalence of Alopecia areata is higher in the age group of 10 and 25 years and around 60% of people under these age group suffers from Alopecia areata. Therefore, high prevalence of alopecia is expected to propel demand for its treatment drugs, which in turn is expected to create a lucrative environment for the global alopecia treatment market growth in near future.

The presence of alternative treatment option for alopecia is expected to be major factor restraining the global alopecia treatment market growth in near future. For instance, methods such as hair transplant surgery, laser and light-based therapies are expected to hinder the growth of market.

Key Players - Alopecia Treatment Market

Key players operating in the alopecia treatment market include Histogen, Inc., Aclaris Therapeutics, Inc., Concert Pharmaceuticals, Inc., HCell Inc., GlaxoSmithKline Plc., Daiichi Sankyo, Inc., Cipla Limited, and others.

Else Place an Enquiry Before Purchase at https://www.coherentmarketinsights.com/insight/talk-to-analyst/1847

Market Detailed Segmentation:

Global Alopecia Treatment Market, By Disease Type :
Androgenic Alopecia
Alopecia Areata
Ciatricial Alopecia
Traction Alopecia
Alopecia Totalis

Global Alopecia Treatment Market, By Drug Type:
Vasodilators
- Minoxidil
5-Alpha Reductase Inhibitors
- Finasteride
Corticosteroids
Immunosuppressants
- Cyclosporine
- Others
Others

Global Alopecia Treatment Market, By Gender:
Male
Female

Global Alopecia Treatment Market, By Route of Administration:
Oral
Topical
Injectable

Global Alopecia treatment market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Alopecia treatment market, By Geography:
North America
Europe
Asia Pacific
Latin America
Middle East
Africa

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1847

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Alopecia Treatment Market Analysis of Valuable Foresights on How Alopecia Treatment will Grow by 2026 Evaluated By Global Players Cipla Limited, GlaxoSmithKline Plc., Histogen, Inc., Aclaris Therapeutics, Inc., Concert Pharmaceuticals, Inc., Daiichi Sanky here

News-ID: 1536799 • Views: 778

More Releases from Coherent Market Insights

Computational Biology Market - Detailed Analysis of Current and Future Industry …
Global Computational Biology Market Insights, Forecast to 2027 is latest research study re-leased by CMI evaluating the market, highlighting opportunities, risk side analysis, and lever-aged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Computational Biology Market. Some of the key players profiled in the study are Accelrys, Certara, L.P., Chemical Computing
Telerehabilitation Systems Market - Detailed Analysis of Current and Future Indu …
Global Telerehabilitation Systems Market Insights, Forecast to 2027 is latest research study re-leased by CMI evaluating the market, highlighting opportunities, risk side analysis, and lever-aged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Telerehabilitation Systems Market. Some of the key players profiled in the study are Reflexion Health, Inc., 270 Vision
Personal Emergency Response Systems Market - Detailed Analysis of Current and Fu …
Global Personal Emergency Response Systems Market Insights, Forecast to 2027 is latest research study re-leased by CMI evaluating the market, highlighting opportunities, risk side analysis, and lever-aged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Personal Emergency Response Systems Market. Some of the key players profiled in the study are Koninklijke
Wearable Patch Market - Detailed Analysis of Current and Future Industry Figures …
Global Wearable Patch Market Insights, Forecast to 2027 is latest research study re-leased by CMI evaluating the market, highlighting opportunities, risk side analysis, and lever-aged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Wearable Patch Market. Some of the key players profiled in the study are Medtronic Plc, Hill-Rom Holdings, Inc.

All 5 Releases


More Releases for Alopecia

Alopecia Market Size, Share & Trends| Industry Report 2026
The global Alopecia Market was valued at $21.60Billion in 2018 and is forecast to grow at a modest8.2 % CAGR between 2018 and 2025, culminating in 2026 global sales of $28.04 Billion. Alopecia is a disease which causes hair to fall in small patches with the unnoticeable time period of a human body. In this disease the immune system directly attacks to the hair follicles, resulting in hair losses, hair
Alopecia Drugs Market Outlook till 2018 to 2022 | By Alopecia Type Alopecia Area …
Market Research Future Published a Prime Research Report on Global Alopecia Drugs Market. The global Alopecia Drugs Market is expected to grow at a CAGR of 6.92% during the Period 2018 to 2022. “Alopecia Drugs Market” Completed Major Study of Alopecia Drugs in Market Research Future. This Report aim is Provide Insights about Factors Affecting the Market Growth. Market Scenario of Global Alopecia Drugs Market: Alopecia is loss of hair due to a
Alopecia Treatment Market - Global Forecast to 2026
Alopecia also called as hair-loss or baldness is a medical condition that refers to loss of hairs from head or any part of the body. The condition can occur in both male and female and at any age. There are five major type of alopecia namely; alopecia areata, androgenic alopecia, ciatricial alopecia, traction alopecia, and alopecia totalis. Alopecia areata is a common autoimmune disorder in which the immune system of
Alopecia Treatment Market - Global Forecast to 2026
Alopecia also called as hair-loss or baldness is a medical condition that refers to loss of hairs from head or any part of the body. The condition can occur in both male and female and at any age. There are five major type of alopecia namely; alopecia areata, androgenic alopecia, ciatricial alopecia, traction alopecia, and alopecia totalis. Alopecia areata is a common autoimmune disorder in which the immune system of
Alopecia Drugs Industry Analysis and Global Forecast to 2022
Alopecia Drugs Market is expected to reach around $ 11.8 billion by the end of the forecast period and is expected to grow at a CAGR of ~ 6.92%. The primary market drivers are genetics, increasing awareness, modern lifestyle changes, stress, drug-induced alopecia etc. The constraining factors are unethical spurious products, poor efficacy and efficiency of treatment resulting in poor economics to the patient, neglect of alopecia as it
Alopecia Drugs Market 2022 Industry Growth with Key Manufacturers Analysis
Market Research Future published a research report on “Alopecia Drugs Market Research Report- Global Forecast to 2022”– Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022. Global Alopecia Drugs Market Information, by alopecia type (alopecia areata, alopecia totalis, and alopecia universalis), by product type (tropical, oral and others), by end user (hospitals and clinics, saloons and home care) - Forecast till 2022 Market Synopsis of Global Alopecia Drugs Market: Market Scenario: Alopecia